ReviewMayo Clinic proceedings. Innovations, quality & outcomes2021
Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic Review.
Review in Mayo Clinic proceedings. Innovations, quality & outcomes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Doctors' Conflict-of-Interest; What it Looks Like and What to do About it.International journal of social determinants of health and health services · 2026Article
- Level of Evidence and Strength of Recommendations in US Medical Society Clinical Practice Guidelines, 2019-2023: A Cross-Sectional Analysis.Journal of general internal medicine · 2026Article
- Evaluating conflict-of-interest governance among Canadian medical societies using a novel assessment tool: A cross-sectional study.PloS one · 2026Article
- Evaluation of clinical guideline implementations for cardiovascular diseases by German general practitioners-Results of a web-based survey.Frontiers in medicine · 2026Article
- Brief report of a pilot test of an audit tool for assurance of Declarations of Interest policy in NICE COVID-19 guidance production.Clinical and public health guidelines · 2025Article
- Increasing the focus on critical appraisal of trials and financial conflict of interest in medical training programs: a perspective from oncology.Frontiers in medicine · 2025Article
- Trends in enforcement of National Comprehensive Cancer Network financial conflict of interest policy.JNCI cancer spectrum · 2024Article
- Financial conflicts of interest among authors of clinical practice guideline for headache disorders in Japan.BMC medical ethics · 2024Article
- Pharmaceutical industry payments to authors of neurology clinical practice guidelines in Japan: A cross-sectional study.Health science reports · 2024Article
- Industry payments to American Society of Hematology Clinical Practice Guideline authors.Blood advances · 2024Article
- Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan.BMC medical ethics · 2024Article
- Association between Conflicts of Interest Disclosure and Quality of Clinical Practice Guidelines in Japan: A Meta-Epidemiological Study.Journal of personalized medicine · 2023Article
- Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019.International urogynecology journal · 2023Article
- Transparency of clinical practice guideline funding: a cross-sectional analysis of the German AWMF registry.BMC medical ethics · 2023Article
- How to recognize a trustworthy clinical practice guideline.Journal of anesthesia, analgesia and critical care · 2023Review
- Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry.JAMA network open · 2023Article
- Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?Clinical drug investigation · 2023Review
- Article
- Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study.BMJ open · 2023Article
- Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database.PloS one · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo systematically evaluate the prevalence of disclosed and undisclosed financial conflicts of interest (FCOI) among clinical practice guidelines (CPGs).
methodsIn this systematic review, we ascertained the prevalence and types of FCOI for CPGs from January 1, 1980, to March 3, 2019. The primary outcome was the prevalence of FCOI among authors of CPGs. FCOI disclosures were compared between medical subspecialties and societies producing CPGs.
resultsAmong the 37 studies including 14,764 total guideline authors, 45% had at least one FCOI. The prevalence of FCOI per study ranged from 6% to 100%. More authors had FCOI involving general payments (39%) compared with research payments (29%). Oncology, neurology, and gastroenterology had the highest prevalence of FCOI compared with other medical specialties. Among the 8 studies that included the monetary values in US dollars of FCOI, average payments per author ranged from $578 to $242,300. Among the 10 studies that included data on undisclosed FCOI, 32% of authors had undisclosed industry payments.
conclusionThere are numerous FCOI among authors of CPGs, many of which are undisclosed
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.